A pair of medical device industry studies find weak VC activity but M&A remains strong


The venture capital market remains weak, but M&A activity is still strong and R&D spending is on an upward swing, two state-of-the-industry reports released by EY (formerly Ernst & Young) and EvaluateMedTech conclude at the annual AdvaMed industry conference.

Total VC funding fell 2.4% between July 2014 and June 2015 to $4.7 billion. Med tech’s share of total VC funding fell to a decade low of 5.9%, and a lower percentage of med tech deals went to early-stage companies. That metric fell from 37% to 29% of all med tech deals.


About Peter Coffaro 1436 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.